Entrada Therapeutics
Stock Forecast, Prediction & Price Target

Entrada Therapeutics (TRDA) stock Price Target by analysts

Last Year
Average Price Target

$20

Potential upside: 263.63%

Based on 1 analysts

Entrada Therapeutics price prediction

Strike.market

What is Entrada Therapeutics stock analysts` prediction?

Entrada Therapeutics stock forecast: Based on 1 Wall Street analysts` predicted price targets for Entrada Therapeutics in the last 3 months, the avarage price target is $20, with a high forecast of $NaN. The average price target represents a 263.63% change from the last price of $5.5.

Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.

Entrada Therapeutics stock Price Target by analysts

Full breakdown of analysts given Entrada Therapeutics price targets

Analyst name & company
Analyst win rate
Publish date
Price target
Price when posted
Source Historical targets
Boobalan Pachaiyappan
H.C. Wainwright
0%
0/1
10 months ago $20 263.63% upside $18.03 StreetInsider
Previous targets (0)
Raghuram Selvaraju
H.C. Wainwright
0%
0/1
about 1 year ago $18 227.27% upside $14.24 TheFly
Previous targets (0)

Entrada Therapeutics Financial Estimates

Entrada Therapeutics Revenue Estimates

Entrada Therapeutics EBITDA Estimates

Entrada Therapeutics Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$129.01M
 
0%
Avg: $45.68M
Low: $36.66M
High: $57.29M
avg. -64.59%
Avg: $45.10M
Low: $40.92M
High: $51.24M
avg. -1.25%
Avg: $174.21M
Low: $158.06M
High: $197.92M
avg. 286.24%
Avg: $304.76M
Low: $276.51M
High: $346.24M
avg. 74.93%
Net Income
 
% change YoY
$-50.07M
 
N/A
$-87.45M
 
-74.66%
$-6.68M
 
92.35%
Avg: $-138.08M
Low: $-142.11M
High: $-73.04M
avg. -1965.60%
Avg: $-158.58M
Low: $-145.42M
High: $-92.87M
avg. -14.84%
Avg: $-144.42M
Low: $-169.98M
High: $-127.02M
avg. 8.92%
Avg: $21.64M
Low: $19.03M
High: $25.47M
avg. 114.98%
EBITDA
 
% change YoY
$-51.12M
 
N/A
$-97.24M
 
-90.20%
$-321K
 
99.66%
Avg: $36.52M
Low: $29.31M
High: $45.80M
avg. 11477.34%
Avg: $36.06M
Low: $32.71M
High: $40.96M
avg. -1.25%
Avg: $139.28M
Low: $126.37M
High: $158.24M
avg. 286.24%
Avg: $243.66M
Low: $221.07M
High: $276.82M
avg. 74.93%
EPS
 
% change YoY
-$1.6
 
N/A
-$2.79
 
-74.37%
-$0.2
 
92.83%
Avg: -$3.48
Low: -$4.3
High: -$2.21
avg. -1641.24%
Avg: -$3.63
Low: -$4.4
High: -$2.81
avg. -4.13%
Avg: -$4.37
Low: -$5.14
High: -$3.84
avg. -20.49%
Avg: $0.66
Low: $0.58
High: $0.77
avg. 114.98%
Operating Expenses
 
% change YoY
$51.12M
 
N/A
$97.24M
 
90.20%
$132.17M
 
35.91%
Avg: $38.83M
Low: $31.16M
High: $48.70M
avg. -70.62%
Avg: $38.34M
Low: $34.78M
High: $43.56M
avg. -1.25%
Avg: $148.09M
Low: $134.36M
High: $168.25M
avg. 286.24%
Avg: $259.07M
Low: $235.05M
High: $294.32M
avg. 74.93%

FAQ

What is Entrada Therapeutics stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of -464.13% in 2025-2028.

We have gathered data from 4 analysts. Their low estimate is -142.11M, average is -138.08M and high is -73.04M.

What is Entrada Therapeutics stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 73.83% in 2025-2028.

We have gathered data from 4 analysts. Their low revenue estimate is $36.66M, average is $45.68M and high is $57.29M.

What is Entrada Therapeutics stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of -387.72% in 2025-2028.

We have gathered data from 4 analysts. Their low earnings per share estimate is -$4.3, average is -$3.48 and high is $-2.21.

What is the best performing analyst?

In the last twelve months 1 analysts have been covering Entrada Therapeutics stock. The most successful analyst is Boobalan Pachaiyappan.